Patent · US Active

Lactobacillus rhamnosus strain for reducing body fat accumulation

US9855304B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignees

Compagnie Gervais Danone · FR
BIOPOLIS, S.L. · ES

Inventors

Gianfranco Grompone · Paris, FR
Daniel Ramon Vidal · València, ES
Patricia Martorell Guerola · Picassent, ES
Salvador Genoves Martinez · Aldaia, ES
Josefa Ortiz Serrano · València, ES
Silvia Llopis Pla · València, ES
Nuria Gonzalez Martinez · València, ES

Key dates

Filing date	Nov 12, 2012
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Jun 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/115
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of Lactobacillus rhamnosus strain CNCM 1-3690 for reducing body fat accumulation and treating disorders resulting therefrom, such as overweight, obesity, and obesity-related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.